Corona Remedies Ltd PE Ratio

Corona Remedies PE Ratio

Image

Corona Remedies Ltd

NSE: CORONA

PE

61.7

Last updated on: Aug 22, 2026

Key Highlights

  • The P/E Ratio of Corona Remedies Ltd is 61.7 as of 22 Aug 09:05 AM The P/E Ratio of Corona Remedies Ltd changed from 51.4 on March 2026 to 51.4 on March 2026 . This represents a CAGR of 0.00% over 1 years The Latest Trading Price of Corona Remedies Ltd is ₹ 2139 as of 21 Aug 15:30 The PE Ratio of Pharmaceuticals Industry has changed from 24.6 to 32.5 in 5 years. This represents a CAGR of 5.73% The PE Ratio of Automobile industry is 12.4. The PE Ratio of Finance industry is 16.3. The PE Ratio of IT - Software industry is 18.4. The PE Ratio of Pharmaceuticals industry is 31.7. The PE Ratio of Retail industry is 96.2. The PE Ratio of Textiles industry is 40.0 in 2026 .

Historical P/E Ratio of Corona Remedies Ltd

No data available

Company Fundamentals for Corona Remedies Ltd

Image

Corona Remedies Ltd

NSE: CORONA

Share Price

₹ 2139.9

-24.60 (-1.14%)

stock direction

Last updated on: Aug 21, 2026

Market Price of Corona Remedies Ltd

1M

1Y

3Y

5Y

Monitoring Corona Remedies Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Aug 20262139.9
20 Aug 20262164.5
19 Aug 20262123.85
18 Aug 20262114.8
17 Aug 20262113.55
14 Aug 20262144.05
13 Aug 20262112.3
12 Aug 20262136
11 Aug 20262104.25
10 Aug 20262082.35

SWOT Analysis Of Corona Remedies Ltd

Strength

1

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Corona Remedies Ltd

Asset Value vs Market Value of Corona Remedies Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Corona Remedies Ltd13087
Sun Pharmaceutical Industries Ltd456114
Divis Laboratories Ltd227958
Torrent Pharmaceuticals Ltd189990
Cipla Ltd116141
Zydus Lifesciences Ltd110603

PE Ratio of Corona Remedies Ltd Explained

13087

Market cap

199

Earnings

61.7X

PE Ratio

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Corona Remedies Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Corona Remedies Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Corona Remedies Ltd

No data available

* All values are in %

About Corona Remedies Ltd

  • Corona Remedies Limited was originally incorporated as CORONA Remedies Private Limited', a private limited company, dated August 27, 2004, issued by the Assistant Registrar of Companies, Gujarat at Dadra and Nagar Haveli.
  • Thereafter, Company converted into a public limited and Company name has changed to CORONA Remedies Limited'.
  • A fresh certificate of incorporation, is issued by the Registrar of Companies, Central Processing Centre, Manesar, Haryana on December 16, 2024. The manufacturing facilities of the Company are located at Solan (Himachal Pradesh) and at Bhayla (Ahmedabad, Gujarat).
  • The Company is engaged in manufacturing, trading and marketing of Pharmaceutical products in women's healthcare, cardio-diabeto, pain management, urology and other therapeutic areas. In 2004, Company launched the first division, and later named it as Pioneer' division in year 2010; launched Xemx (multispeciality) division in 2005.

Corona Remedies Ltd News Hub

Corona Remedies to announce Quarterly Result

Corona Remedies will hold a meeting of the Board of Directors of the Company on 31 July 2026.

Read more

18 Jul 26

Shares of Corona Remedies list in B group

The equity shares of Corona Remedies (Scrip Code: 544644) are listed effective 15 December 2025 and

Read more

15 Dec 25

Corona Remedies Q2 PAT climbs 22% YoY to Rs 52 cr

Profit before tax (PBT) increased 21.67% year on year (YoY) to Rs 69.78 crore in Q2 FY26. Earnings B

Read more

03 Jan 26

Corona Remedies gains as Q2 PAT climbs 22% YoY to Rs 52 cr

Profit before tax (PBT) increased 21.67% year on year (YoY) to Rs 69.78 crore in Q2 FY26. Earnings B

Read more

05 Jan 26

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Corona Remedies Ltd

What is the current PE Ratio of Corona Remedies Ltd?

The Current PE Ratio of Corona Remedies Ltd is 61.67 as on 22 Aug 2026.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 31.7 as on 22 Aug 2026.

What was the PE Ratio of Corona Remedies Ltd last year?

The PE Ratio of Corona Remedies Ltd was 0.0 last year, now the PE ratio is 61.67, showing a year-on-year growth of -%.

What does the PE Ratio of Corona Remedies Ltd indicate about its stock?

The PE Ratio of Corona Remedies Ltd is 61.67. This ratio indicates that investors are willing to pay 61.67 times the earnings per share for each share of Corona Remedies Ltd.

What is the PE Ratio Growth of Corona Remedies Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Corona Remedies Ltd grew by -% whereas, the EPS ratio grew by 32.7.

How does the PE ratio of Corona Remedies Ltd compare to industry peers?

The PE ratio of Corona Remedies Ltd PE Ratio can indicate whether it is overvalued or undervalued compared to competitors in the same industry. A lower PE ratio may suggest an undervalued stock, while a higher PE ratio could indicate premium pricing.

Is a high PE ratio for Corona Remedies Ltd PE Ratio good or bad?

A high PE ratio may indicate strong future growth expectations, but it can also suggest overvaluation. It is best to compare it with industry averages and historical trends of Corona Remedies Ltd PE Ratio.

What factors influence the PE ratio of Corona Remedies Ltd PE Ratio?

The PE ratio of Corona Remedies Ltd PE Ratio is influenced by factors such as earnings growth, investor sentiment, macroeconomic conditions, and sector trends.

How often does the PE ratio of Corona Remedies Ltd PE Ratio change?

The PE ratio changes as the share price or earnings of Corona Remedies Ltd PE Ratio fluctuate, and it is updated whenever there is a significant movement in either of these factors.

Where can I find the latest PE ratio of Corona Remedies Ltd PE Ratio?

You can check the latest PE ratio of Corona Remedies Ltd PE Ratio on BlinkX Website above or any other stock market platforms, or at the company’s official website.

What is a good PE ratio for Corona Remedies Ltd PE Ratio?

A "good" PE ratio depends on industry standards and market conditions. It is advisable to compare Corona Remedies Ltd PE ratio with its historical average and competitors.

Can the PE ratio of Corona Remedies Ltd PE Ratio predict future stock performance?

While the Corona Remedies Ltd PE ratio is a useful indicator of valuation, it should be used alongside other financial metrics and market analysis to make informed investment decisions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions